AAIC 2025 Abstract·26 DecPRImus‐AD study: Design of the phase 2 study treating patients with MCI or mild dementia due to Alzheimer’s disease (AD) with the orally available PRI‐002Trial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecAnti‐oligomeric PRI‐002 does not cause ARIA‐E in an ongoing Phase 2 trialTrial in peopleInterventionsPaper